Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.
Pharma Mar Dividend Announcement
• Pharma Mar announced a annually dividend of €0.65 per ordinary share which will be made payable on 2024-06-14. Ex dividend date: 2024-06-12
• Pharma Mar annual dividend for 2024 was €0.65
• Pharma Mar annual dividend for 2023 was €0.65
• Pharma Mar's trailing twelve-month (TTM) dividend yield is 0.88%
• Pharma Mar's payout ratio for the trailing twelve months (TTM) is 1836.01%
Pharma Mar Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-12 | €0.65 | annually | 2024-06-14 |
2023-06-07 | €0.65 | annually | 2023-06-09 |
2022-07-13 | €0.65 | annually | 2022-07-15 |
2021-04-28 | €0.60 | annually | 2021-04-30 |
2020-06-26 | €0.04 | annually | 2020-06-30 |
Pharma Mar Dividend per year
Pharma Mar Dividend growth
Pharma Mar Dividend Yield
Pharma Mar current trailing twelve-month (TTM) dividend yield is 0.88%. Interested in purchasing Pharma Mar stock? Use our calculator to estimate your expected dividend yield:
Pharma Mar Financial Ratios
Pharma Mar Dividend FAQ
Other factors to consider when evaluating Pharma Mar as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Pharma Mar stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Pharma Mar's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Pharma Mar publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Pharma Mar distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Pharma Mar are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Pharma Mar sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Pharma Mar distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Pharma Mar declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Pharma Mar's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Pharma Mar's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.